BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18024878)

  • 1. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
    Pinedo DM; Shah-Khan F; Shah PC
    J Clin Oncol; 2007 Nov; 25(33):5320-1. PubMed ID: 18024878
    [No Abstract]   [Full Text] [Related]  

  • 2. Bortezomib-induced reversible posterior leucoencephalopathy syndrome.
    Kelly K; Kalachand R; Murphy P
    Br J Haematol; 2008 May; 141(5):566. PubMed ID: 18325065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reversible posterior leukoencephalopathy: the guilty list is increasing].
    Alaña M; Navarro M; Pascual J
    Neurologia; 2008 Mar; 23(2):137; author reply 137-8. PubMed ID: 18322836
    [No Abstract]   [Full Text] [Related]  

  • 4. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.
    Femia G; Hardy TA; Spies JM; Horvath LG
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):115-22. PubMed ID: 22524570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin-induced posterior reversible encephalopathy syndrome with isolated involvement of pons.
    Tang KH
    J Cancer Res Ther; 2015; 11(4):1022. PubMed ID: 26881576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cisplatin induced reversible posterior leukoencephalopathy].
    Díaz Díaz J; Germán Díaz M; Barrios López M; Martinez De Aragón A; Simón De Las Heras R; Camacho Salas A
    An Pediatr (Barc); 2012 Oct; 77(4):281-2. PubMed ID: 22459609
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
    Skelton MR; Goldberg RM; O'Neil BH
    Clin Colorectal Cancer; 2007 Jan; 6(5):386-8. PubMed ID: 17311705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible posterior encephalopathy syndrome associated with bortezomib.
    Terwiel E; Hanrahan R; Lueck C; D'Rozario J
    Intern Med J; 2010 Jan; 40(1):69-71. PubMed ID: 20561367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).
    Janjua TK; Hassan M; Afridi HK; Zahid NA
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PRES--posterior reversible encephalopathy syndrome].
    Harefuah; 2007 Dec; 146(12):1 p before 914. PubMed ID: 18254438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reversible posterior leukoencephalopathy syndrome with the neuroradiological abnormalities predominantly in the brainstem].
    Abiko M; Ikawa F; Obayashi N; Kajiwara Y; Mitsuhara T; Ichinose N; Inagawa T
    Brain Nerve; 2008 Sep; 60(9):1080-1. PubMed ID: 18807944
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)].
    Nagata Y; Omuro Y; Shimoyama T; Sasaki E; Okamoto R; Maeda Y; Kishida S; Sasaki T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1163-6. PubMed ID: 19620809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil.
    Truman N; Nethercott D
    Clin Colorectal Cancer; 2013 Mar; 12(1):70-2. PubMed ID: 22917935
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs.
    Marinella MA; Markert RJ
    Intern Med J; 2009 Dec; 39(12):826-34. PubMed ID: 19220526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible palpebral ptosis following oxaliplatin infusion.
    La Verde N; Garassino MC; Spinelli G; Scanni A; Sburlati P; Farina G; Labianca R
    Dig Liver Dis; 2007 Nov; 39(11):1041. PubMed ID: 17913604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reversible posterior leukoencephalopathy syndrome in patients with immunosuppressive treatment: report of four cases].
    Hernández Ch M; Núñez F A; Mesa L T; Escobar H R; Barriga C F; Huete L I
    Rev Med Chil; 2008 Jan; 136(1):93-8. PubMed ID: 18483659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult male with altered mental status and new-onset seizures. Posterior reversible leukoencephalopathy.
    Solomon DM; Saccio M; Savarese K; Hahn B
    Ann Emerg Med; 2010 Feb; 55(2):225-31. PubMed ID: 20116033
    [No Abstract]   [Full Text] [Related]  

  • 19. Puzzles in practice. Posterior reversible encephalopathy syndrome.
    Mishriki YY
    Postgrad Med; 2009 Mar; 121(2):192-4. PubMed ID: 19332978
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.
    Myint ZW; Sen JM; Watts NL; Druzgal TJ; Nathan BR; Ward MD; Boyer JE; Fracasso PM
    Clin Colorectal Cancer; 2014 Jun; 13(2):127-30. PubMed ID: 24461491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.